Lonza Group AG
(OTC: LZAGY)
|
4:59 PM UTC, 07/03/24 | |||
---|---|---|---|---|
Last: $55.15 | Change: +1.33 | %Change: +2.47% | Volume: 18,425 |
Open: | $ 54.95 | Volume: | 18,425 | |
---|---|---|---|---|
High: | $ 55.45 | Yield(%) | 0.59 | |
Low: | $ 54.91 | P/E Ratio (ttm): | 54.49 | |
Dividend ($): | 0.32 | Market Cap ($): | 37.63B | |
EPS ($) | n/a | Shares Out: | 698.74M |
% Price Change (last 4 weeks): | -2.59 |
---|---|
% Price Change (last 13 weeks): | -8.42 |
% Price Change (last 26 weeks): | 29.23 |
% Price Change (last 52 weeks): | -8.82 |
% Price Change (year to date): | 28.16 |
Return on Equity (%): | 6.42 |
---|---|
Return on Assets (%): | 3.71 |
Return on Invested Capital (%): | 7.16 |
Gross Profit Margin (%): | 27.04 |
---|---|
Net Profit Margin (%): | 9.74 |
Operating Profit Margin (%): | 12.71 |
|
|
50-day Moving Average: | $55.70 |
---|---|
200-day Moving Average: | $48.69 |
Avg. Daily Vol. (last 50 days): | 35,042 |
Avg. Daily Vol. (last 200 days): | 173,380 |
52-wk high: | $64.88 |
52-wk low: | $34.19 |
Bid: | $n/a |
Ask: | $n/a |
Lonza Group AG is engaged in the supply of pharmaceutical, healthcare, and life science products. It operates through the following segments: Biologics, Small Molecules, Cell and Gene, Capsule and Health Ingredients, and Corporate. The Biologics segment serves as contract development and manufacturing partner for biopharmaceuticals, catering customers for all clinical and commercial manufacturing needs throughout the product lifecycle. The Small Molecules segment offers small molecule drug substances and intermediates related services. The Cell and Gene segment includes the Cell and Gene Technologies and Bioscience businesses. The Capsule and Health Ingredients segment provides innovative capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical companies. The Corporate segment refers to finance and accounting, legal, communication, information technology, and human resources functions. The company was founded on October 27, 1897 and is headquartered in Basel, Switzerland.
|
Lonza Group AG
Muenchensteinerstrasse 38 Basel BS 4002 Phone: 41.61.316.81.11 Fax: 41.61.316.91.11 http://www.lonza.com |
Earnings (1year) ($): | 0.99 |
---|---|
Annual Dividend ($): | 0.32 |
Current P/E Ratio (ttm): | 54.49 |
Book Value ($): | 15.57 |
Cash Flow ($): | 1.97 |
Price/Earnings (x): | 54.49 |
---|---|
Price/Sales (x): | 4.14 |
Price/Book (x): | 2.70 |
Price/Cash Flow (x): | 19.61 |
Quick Ratio (x): | 1.19 |
---|---|
Current Ratio (x): | 1.77 |
LT Debt/Equity (x): | 30.73 |
Total Debt/Equity (x): | 33.14 |